110 related articles for article (PubMed ID: 8177907)
1. Integrated cardiovascular function in the conscious streptozotocin-diabetic deoxycorticosterone-acetate-hypertensive rats.
Schenk J; Hebden RA; Dai S; McNeill JH
Pharmacology; 1994 Apr; 48(4):211-5. PubMed ID: 8177907
[TBL] [Abstract][Full Text] [Related]
2. Myocardial performance of STZ-diabetic DOCA-hypertensive rats.
Dai S; McNeill JH
Am J Physiol; 1992 Dec; 263(6 Pt 2):H1798-805. PubMed ID: 1481903
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of different rat models with co-existing diabetes-mellitus and hypertension.
Hakim ZS; Goyal RK
Indian J Physiol Pharmacol; 2000 Apr; 44(2):125-35. PubMed ID: 10846625
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-term treatment with enalapril in streptozotocin diabetic and DOCA hypertensive rats.
Goyal RK; Satia MC; Bangaru RA; Gandhi TP
J Cardiovasc Pharmacol; 1998 Aug; 32(2):317-22. PubMed ID: 9700996
[TBL] [Abstract][Full Text] [Related]
5. Effects of deoxycorticosterone acetate on glucose metabolism in nondiabetic and streptozotocin-diabetic rats.
Dai S; Fraser H; McNeill JH
Can J Physiol Pharmacol; 1992 Nov; 70(11):1468-72. PubMed ID: 1296859
[TBL] [Abstract][Full Text] [Related]
6. Effects of chronic treatment with lisinopril on cardiovascular complications in streptozotocin diabetic and DOCA hypertensive rats.
Sevak AR; Goyal RK
Pharmacol Res; 1996; 34(5-6):201-9. PubMed ID: 9076844
[TBL] [Abstract][Full Text] [Related]
7. Changes in diastolic function and collagen content in normotensive and hypertensive rats with long-term streptozotocin-induced diabetes.
Riva E; Andreoni G; Bianchi R; Latini R; Luvarà G; Jeremic G; Traquandi C; Tuccinardi L
Pharmacol Res; 1998 Mar; 37(3):233-40. PubMed ID: 9602473
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic responsiveness in DOCA hypertensive rats augmented by streptozotocin-induced diabetes.
Sasaki S; Buñag RD
J Cardiovasc Pharmacol; 1982; 4(6):1042-8. PubMed ID: 6185770
[TBL] [Abstract][Full Text] [Related]
9. Effects of simultaneous diabetes and hypertension in an insulin dependent diabetic model.
Mozaffari MS; Jirakulsomchok S; Wyss JM
Int J Exp Pathol; 1991 Dec; 72(6):655-64. PubMed ID: 1768611
[TBL] [Abstract][Full Text] [Related]
10. Dietary magnesium supplementation modifies blood pressure and cardiovascular function in mineralocorticoid-salt hypertensive rats but not in normotensive rats.
Laurant P; Kantelip JP; Berthelot A
J Nutr; 1995 Apr; 125(4):830-41. PubMed ID: 7722684
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular and metabolic changes in spontaneously hypertensive rats following streptozotocin administration.
Dai S; Lee S; Battell M; McNeill JH
Can J Cardiol; 1994 Jun; 10(5):562-70. PubMed ID: 8012888
[TBL] [Abstract][Full Text] [Related]
12. Attenuated cardioprotective response to bradykinin, but not classical ischaemic preconditioning, in DOCA-salt hypertensive left ventricular hypertrophy.
Ebrahim Z; Yellon DM; Baxter GF
Pharmacol Res; 2007 Jan; 55(1):42-8. PubMed ID: 17079163
[TBL] [Abstract][Full Text] [Related]
13. meta-iodobenzylguanidine uptake in the hypertensive-diabetic rat heart: a marker for myocardial dysfunction?
Herman LM; Dai S; Hartman NG; McNeill JH
Can J Physiol Pharmacol; 1994 Oct; 72(10):1162-7. PubMed ID: 7882180
[TBL] [Abstract][Full Text] [Related]
14. Association of DOCA hypertension with induction of atherosclerosis in rats with short-term diabetes mellitus.
Hebden RA; Todd ME; Tang C; Gowen B; McNeill JH
Am J Physiol; 1990 Apr; 258(4 Pt 2):R1042-50. PubMed ID: 2331024
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of clonidine in streptozotocin-induced diabetes and DOCA-hypertensive rats.
Satia MC; Damani RR; Goyal RK
J Pharm Pharmacol; 1997 Oct; 49(10):1030-5. PubMed ID: 9364415
[TBL] [Abstract][Full Text] [Related]
16. Investigation into the cardiac effects of spironolactone in the experimental model of type 1 diabetes.
Goyal BR; Solanki N; Goyal RK; Mehta AA
J Cardiovasc Pharmacol; 2009 Dec; 54(6):502-9. PubMed ID: 19738487
[TBL] [Abstract][Full Text] [Related]
17. Effect of exercise training on liver antioxidant status of deoxycorticosterone acetate salt induced hypertensive rats.
Elhaïmeur F; Courderot-Masuyer C; Nicod L; Bobillier-Chaumont S; Robin S; Richert L; Berthelot A
Can J Physiol Pharmacol; 2003 May; 81(5):469-75. PubMed ID: 12774853
[TBL] [Abstract][Full Text] [Related]
18. [Effects of tetrandrine on cardiac hemodynamics of hypertrophied left ventricle from deoxycorticosterone-salt hypertensive rats].
Xu Y; Rao MR
Yao Xue Xue Bao; 1995; 30(2):86-92. PubMed ID: 7785436
[TBL] [Abstract][Full Text] [Related]
19. Systemic and regional hemodynamic effect of acute magnesium administration in the normotensive and hypertensive state.
DiPette DJ; Simpson K; Guntupalli J
Magnesium; 1987; 6(3):136-49. PubMed ID: 3626625
[TBL] [Abstract][Full Text] [Related]
20. Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats.
Chan V; Hoey A; Brown L
Br J Pharmacol; 2006 Aug; 148(7):902-8. PubMed ID: 16783413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
